Advertisement
Screener

JAMES HARDIE INDUSTRIES plc (JHX) Spending and interest coverage

JAMES HARDIE INDUSTRIES plc (JHX) Spending and interest coverage

  • R&D / revenue · 12 months: Value 1.18%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
  • Stock-based compensation / revenue · 12 months: Value 0.80%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months1.18%Research and development expense / revenue. Period ending 2026-06-30.

$64.00M ÷ $5.41B × 100 ≈ 1.18%

Stock-based compensation / revenue · 12 months0.80%Share-based compensation / revenue. Period ending 2026-06-30.

$43.10M ÷ $5.41B × 100 ≈ 0.80%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending64.00M USDResearch and Development Expense
Revenue5.41B USDRevenue from Contract with Customer, Excluding Assessed Tax
Stock-based compensation43.10M USDShare-based Payment Arrangement, Noncash Expense
Operating income526.70M USDOperating Income (Loss)
Interest expense · reported / estimated(m)Interest Expense · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-06-30$64.00M$5.41B$43.10M$526.70M(m)1.18%0.80%(m)(m)
2026-03-31$60.70M$4.84B$38.00M$447.60M(m)1.26%0.79%(m)(m)
2025-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2025-03-31$48.50M$3.88B$23.00M$655.90M(m)1.25%0.59%(m)(m)
2024-03-31$47.00M$3.94B$28.20M$767.40M(m)1.19%0.72%(m)(m)
2023-03-31$39.60M$3.78B$15.70M$741.40M(m)1.05%0.42%(m)(m)
2022-03-31$38.00M$3.61B$9.00M$682.60M(m)1.05%0.25%(m)(m)
2021-03-31$34.30M$2.91B$18.00M$472.80M(m)1.18%0.62%(m)(m)
2020-03-31$32.80M$2.61B$10.30M$342.50M$57.50M1.26%0.40%5.96×Reported
2019-03-31$37.90M$2.51B$12.50M$351.60M$54.20M1.51%0.50%6.49×Reported
2018-03-31$33.30M(m)$11.10M$229.20M$32.90M(m)(m)6.97×Reported
2017-03-31$30.30M(m)$9.30M$393.20M$28.50M(m)(m)13.80×Reported
2016-03-31$29.50M(m)$10.30M$354.00M$26.60M(m)(m)13.31×Reported
2015-03-31$31.70M(m)$9.20M$335.00M$9.80M(m)(m)34.18×Reported
2014-03-31$33.10M(m)$8.50M$53.10M$4.50M(m)(m)11.80×Reported
2013-03-31$37.20M(m)$7.00M$29.50M$5.50M(m)(m)5.36×Reported
2012-03-31$30.40M(m)$7.80M$155.50M$11.20M(m)(m)13.88×Reported
2011-03-31$28.00M(m)$9.10M$104.70M$9.00M(m)(m)11.63×Reported
2010-03-31$27.10M(m)$7.70M$-21.00M$7.70M(m)(m)-2.73×Reported
2009-03-31$23.80M(m)$7.20M$173.60M$11.20M(m)(m)15.50×Reported

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.